What Is SABR – Webinar

We are delighted to invite you to our next Living With Kidney Cancer Webinar on Tuesday 28th November at 6pm on Zoom titled, ‘What is SABR & What does it mean for kidney cancer patients’. The webinar will feature a presentation from Consultant Clinical Oncologist and honorary Senior lecturer at the University of Birmingham, Dr. Anjali Zarkar, MD, MRCP, FRCR, and a talk from a patient on their experience of SABR. Following the presentation we will open the floor for a full Q&A.

Stereotactic Ablative Body Radiotherapy, also known as ‘SABR’, is a way of giving radiotherapy to precisely target certain cancers, of which kidney cancer is one. SABR increases the chance of controlling the tumour whilst sparing normal tissues. It does this by using fewer treatment sessions, smaller more precise radiation fields, and higher doses of radiation.

But what is SABR, how does it work, and what does it mean for kidney cancer patients…… Dr Anjali Zarkar will explain and answer all your questions.

Registration is FREE but you must register to attend. It’s quick and very simple to do, just click the button below and you are on your way.

To Register Click Here

We look forward to welcoming you to our 22nd Living With Kidney Cancer Webinar – ‘What is SABR & What does it mean for kidney cancer patients’ on the 28th November at 6pm.

ABOUT Dr Anjali Zarkar

Dr Anjali Zarkar is a Consultant Clinical Oncologist and Honorary Senior lecture at the University of Birmingham. She has been consultant for more than 15 years. She has specialist interest in treatment of Kidney cancer (localised and advanced), Prostate cancer (localised and advanced), and bladder cancers (localised and advanced). She is part of multidisciplinary team at University Hospitals Birmingham involving haematological and urological cancers.  She has been Principal investigator for numerous urological clinical trials. She has numerous national and international publications.

She has an interest in stereotactic ablative radiotherapy (called as SABR/ SBRT) especially for patients with localised kidney cancer who are not suitable for surgical excision. The work done at Queen Elizabeth Hospitals Birmingham showed that the stereotactic radiotherapy/ SABR for kidney cancer is safe, effective and can be delivered on the standard radiotherapy machine.

Please note the whole webinar, including the Q&A will be recorded and shared at a later date on our website and social media.